CTMX icon

CytomX Therapeutics
CTMX

Overview Fund Activity

66 hedge funds and large institutions have $28.8M invested in CytomX Therapeutics in 2025 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 20 increasing their positions, 26 reducing their positions, and 11 closing their positions.

Holders
66
Holders Change
-4
Holders Change %
-5.71%
% of All Funds
0.9%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
20
Reduced
26
Closed
11
Calls
$9K
Puts
$30K
Net Calls
-$21K
Net Calls Change
-$52K

Top Buyers

1
WP
1
Woodline Partners
California
$1.05M
2
RCM
2
RA Capital Management
Massachusetts
$636K
3
GCP
3
GSA Capital Partners
United Kingdom
$485K
4
Bank of America
4
Bank of America
North Carolina
$295K
5
UBS Group
5
UBS Group
Switzerland
$475K

Top Sellers

1
Jacobs Levy Equity Management
1
Jacobs Levy Equity Management
New Jersey
$436K
2
SSA
2
Schonfeld Strategic Advisors
New York
$375K
3
ACM
3
Altium Capital Management
New York
$0
4
JPMorgan Chase & Co
4
JPMorgan Chase & Co
New York
$66.9K
5
TCM
5
Tang Capital Management
California
$4.27M
Name Market Value Shares Shares
Change 		Shares
Change %
RCM
76
Raleigh Capital Management
North Carolina
– – -250 Closed
CFGS
77
Concourse Financial Group Securities
Alabama
– – – –
Barclays
78
Barclays
United Kingdom
$0 2 +2 New
1 2 3
4